Hillman Evette B M, Baumgartner Maximilian, Carson Danielle, Amos Gregory C A, Wazir Imad, Khan Haider A, Khan Malik A, Rijpkema Sjoerd, Walters Julian R F, Wellington Elizabeth M H, Arasaradnam Ramesh, Lewis Stephen J
Diagnostics, Medicines and Healthcare Products Regulatory Agency, London, UK.
School of Life Sciences, The University of Warwick, Coventry, UK.
Neurogastroenterol Motil. 2025 Oct;37(10):e70075. doi: 10.1111/nmo.70075. Epub 2025 May 20.
The specific influence of whole gut transit time (WGTT) on microbiome dynamics and bile acid metabolism remains unclear, despite links between changes in WGTT and certain gastrointestinal disorders. Our investigation aimed to determine the impact of WGTT changes on the composition of the fecal microbiome and bile acid profile.
Healthy volunteers (n = 18) received loperamide, to decrease bowel movement frequency, and senna, a laxative, each over a 6-day period, in a randomized sequence, with a minimum 16-day interval between each treatment. Stool samples were analyzed for microbiome by shotgun sequencing and bile acid composition determined with high-performance liquid chromatography coupled to tandem mass spectrometry. Sera were examined for markers of bile acid synthesis.
Senna or loperamide decreased or increased WGTT, respectively. Treatment altered stool characteristics, bowel movement frequency, and stool weight. The senna-treated group had increased primary and secondary fecal bile acids; serum levels of fibroblast growth factor 19 were significantly reduced. Increasing WGTT with loperamide led to an increase in bile salt hydrolase genes, along with elevated bacterial species richness (p = 0.04). Thirty-six species exhibiting significant differences were identified, several of which have notable implications for gut health. WGTT displayed negative correlations with total primary (particularly chenodeoxycholic acid) and secondary bile acids (ursodeoxycholic acid and glycochenodeoxycholic acid). Treatment-induced changes in microbiome composition and bile acid metabolism reverted back to baseline within 16 days.
Whole gut transit time changes significantly affect fecal microbiome composition and function, as well as bile acid composition and synthesis in healthy subjects. This consideration is likely to have long-term implications.
尽管全肠道转运时间(WGTT)的变化与某些胃肠道疾病有关,但其对微生物群动态和胆汁酸代谢的具体影响仍不清楚。我们的研究旨在确定WGTT变化对粪便微生物群组成和胆汁酸谱的影响。
18名健康志愿者以随机顺序在6天内分别服用洛哌丁胺以降低排便频率和番泻叶(一种泻药),每次治疗之间至少间隔16天。通过鸟枪法测序分析粪便样本中的微生物群,并使用高效液相色谱-串联质谱法测定胆汁酸组成。检测血清中的胆汁酸合成标志物。
番泻叶或洛哌丁胺分别降低或增加了WGTT。治疗改变了粪便特征、排便频率和粪便重量。番泻叶治疗组的初级和次级粪便胆汁酸增加;成纤维细胞生长因子19的血清水平显著降低。使用洛哌丁胺增加WGTT导致胆汁盐水解酶基因增加,同时细菌物种丰富度升高(p = 0.04)。鉴定出36种表现出显著差异的物种,其中几种对肠道健康有显著影响。WGTT与总初级胆汁酸(特别是鹅去氧胆酸)和次级胆汁酸(熊去氧胆酸和甘氨鹅去氧胆酸)呈负相关。治疗引起的微生物群组成和胆汁酸代谢变化在16天内恢复到基线水平。
在健康受试者中,全肠道转运时间的变化会显著影响粪便微生物群的组成和功能,以及胆汁酸的组成和合成。这一因素可能具有长期影响。